-
Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment
Wednesday, August 14, 2024 - 2:13pm | 572Kaya Holdings, Inc. (OTCQB:KAYS), a company engaged in the emerging psilocybin treatment sector and medical/recreational cannabis, has voiced strong criticism of the FDA’s decision to reject MDMA therapy as a treatment for post-traumatic stress disorder (PTSD). KAYS, which operates The Sacred...
-
Will This Cannabis Company Also Become A Psilocybin Producer And Facilitator? Here's What They're Thinking
Wednesday, August 3, 2022 - 3:03pm | 342Kaya Holdings Inc., (OTCQB: KAYS), also known as “KAYS,” holder and operator of U.S cannabis licenses in all plant-touching categories, initiated the process of seeking the requisite licenses to manufacture psilocybin and set up facilitation service centers in Oregon. As...
-
Marijuana Company Kaya Receives License For Medical Cannabis Facility In Epidaurus, Greece
Thursday, July 7, 2022 - 9:15am | 393Kaya Holdings, Inc.’s (OTCQB: KAYS) majority owned subsidiary Kaya Farms Greece's second joint venture project, "Greek Kaya," has been issued its crucial cannabis installation license, allowing for the development of a planned medical cannabis facility in Epidaurus, Greece....
-
Kaya Holdings Boosts Operations In Greece With 50% Acquisition Of Epidaurus Medical Cannabis Project
Tuesday, January 11, 2022 - 3:48pm | 487Cannabis company Kaya Holdings, Inc. (OTCQB: KAYS) announced Tuesday that its majority-owned subsidiary Kaya Farms Greece has entered into an agreement to acquire 50% of a medical cannabis project in Epidaurus, Greece. The move marks the company's second cannabis venture in the EU nation. Terms...